Global expansion RTI is actively expanding access to its RT300 and Xcite2 systems with recent launches in KIMES 2026 and market entry in Korea, indicating a growing international sales opportunity and the potential to partner with regional distributors and healthcare providers.

Clinical partnerships The company highlights collaborations with clinicians, researchers, and payers, along with comprehensive training and reimbursement support, suggesting opportunities to engage in joint clinical studies, evidence generation programs, and payer negotiation initiatives to accelerate adoption.

Product lineup A two-system portfolio (RT300 and Xcite2) spanning general and task-specific FES therapy positions RTI to cross-sell to diverse rehabilitation settings, from hospitals to home care, enabling bundle deals, service contracts, and training packages.

Market positioning With a global leadership claim in integrated FES technology and a sizable mid-market employee range, RTI aligns with rehabilitation centers and long-term care facilities seeking innovative neurorehabilitation solutions, presenting channel and enterprise sale opportunities.

Customer value Clinical training, reimbursement support, and data-driven outcomes emphasize outcomes-oriented selling; approach should focus on demonstrating measurable improvements in mobility, spasticity reduction, and quality of life to drive adoption in new and existing accounts.